Tags: Drug.
Florbetaben F18 (BAY-949172) is an investigational diagnostic radiopharmaceutical. It is being developed for the visualization of beta amyloid plaques by PET imaging. It is intended for use in the in vivo diagnosis of Alzhiemer’s disease. It can also be used to study the relationship between beta-amyloid deposition and cognitive impairment.Florbetaben F18 has been submitted to both the Food and Drug Administration and the European Medicines Agency for regulatory approval.
